{"id":56124,"date":"2023-04-24T12:07:31","date_gmt":"2023-04-24T10:07:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/"},"modified":"2023-04-24T12:07:31","modified_gmt":"2023-04-24T10:07:31","slug":"aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/","title":{"rendered":"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023"},"content":{"rendered":"
\n

EDMONTON, Alberta–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the first quarter of 2023, on Thursday, May 4, 2023, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review these results and provide a general business update. Interested participants can dial (888) 645-4404 \/ (862) 298-0702 (Toll-free U.S. & Canada). The audio webcast can also be accessed under “News\/Events\u201d through the \u201cInvestors\u201d section of the Aurinia corporate website at www.auriniapharma.com<\/a>. A replay of the webcast will be available on Aurinia\u2019s website.<\/p>\n

<\/a><\/p>\n

\nAbout Aurinia<\/b><\/p>\n

\nAurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations with a high unmet medical need that are impacted by autoimmune, kidney and rare diseases. In January 2021, the Company introduced LUPKYNIS\u00ae (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis (LN). The Company\u2019s head office is in Edmonton, Alberta, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.<\/p>\n

Contacts<\/b> <\/p>\n

\nAurinia@westwicke.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

EDMONTON, Alberta–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the first quarter of 2023, on Thursday, May 4, 2023, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review these results and provide … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56124","6":"format-standard","7":"category-industry"},"yoast_head":"\nAurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EDMONTON, Alberta–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the first quarter of 2023, on Thursday, May 4, 2023, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review these results and provide ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-24T10:07:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230424005234\/en\/1771371\/21\/aurina_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023\",\"datePublished\":\"2023-04-24T10:07:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/\"},\"wordCount\":204,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005234\\\/en\\\/1771371\\\/21\\\/aurina_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/\",\"name\":\"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005234\\\/en\\\/1771371\\\/21\\\/aurina_logo.jpg\",\"datePublished\":\"2023-04-24T10:07:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005234\\\/en\\\/1771371\\\/21\\\/aurina_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230424005234\\\/en\\\/1771371\\\/21\\\/aurina_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/","og_locale":"en_US","og_type":"article","og_title":"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 - Pharma Trend","og_description":"EDMONTON, Alberta–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that it will release financial and operational results for the first quarter of 2023, on Thursday, May 4, 2023, before markets open. Aurinia\u2019s management team will host a conference call\/webcast at 8:30 am ET that day to review these results and provide ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-24T10:07:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230424005234\/en\/1771371\/21\/aurina_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023","datePublished":"2023-04-24T10:07:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/"},"wordCount":204,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230424005234\/en\/1771371\/21\/aurina_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/","url":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/","name":"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230424005234\/en\/1771371\/21\/aurina_logo.jpg","datePublished":"2023-04-24T10:07:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230424005234\/en\/1771371\/21\/aurina_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230424005234\/en\/1771371\/21\/aurina_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aurinia-pharmaceuticals-to-release-first-quarter-financial-and-operational-results-on-may-4-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 4, 2023"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56124"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56124\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}